Renata Ptáčková

Renata Ptáčková

Auto-generated profile, based on publicly available information

Renata Ptáčková

Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
LBLucie Benesova
Lucie Benesova
THTereza Hálková
Tereza Hálková
RPRenata Ptáčková
Renata Ptáčková
ASAnastasiya Semyakina
Anastasiya Semyakina
KMKateřina Menclová
Kateřina Menclová
MMMarek Minarik
Marek Minarik
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA

14 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MSMateusz Stoszko
Mateusz Stoszko
Abdullah Al-HatmiAbdullah Al-Hatmi
Abdullah Al-Hatmi
ASAnton Skriba
Anton Skriba
MRMichael Roling
Michael Roling
ENEnrico Ne
Enrico Ne
TMTokameh Mahmoudi
Tokameh Mahmoudi
A leading pharmacological strategy toward HIV cure requires “shock” or activation of HIV gene expression in latently infected cells with latency reversal agents (LRAs) followed by their subsequent clearance. In a screen for novel LRAs, we used fungal secondary metabolites as a source of bioactive molecules. Using orthogonal mass spectrometry (MS) coupled to latency reversal bioassays, we identified gliotoxin (GTX) as a novel LRA. GTX significantly induced HIV-1 gene expression in latent ex vivo infected primary cells and in CD4+ T cells from all aviremic HIV-1+ participants. RNA sequencing identified 7SK RNA, the scaffold of the positive transcription elongation factor b (P-TEFb) inhibitory 7SK small nuclear ribonucleoprotein (snRNP) complex, to be significantly reduced upon GTX treatment of CD4+ T cells. GTX directly disrupted 7SK snRNP by targeting La-related protein 7 (LARP7), releasing active P-TEFb, which phosphorylated RNA polymerase II (Pol II) C-terminal domain (CTD), inducing HIV transcription.

Verified
Journal Article
Open access
PDF file
RPRenata Ptáčková
Renata Ptáčková
TJTomas Jecmen
Tomas Jecmen
Petr NovakPetr Novak
Petr Novak
JHJiří Hudeček
Jiří Hudeček
MSMarie Stiborova
Marie Stiborova
MSMiroslav Sulc
Miroslav Sulc
Protein–protein interaction was investigated using a protein nanoprobe capable of photo-initiated cross-linking in combination with high-resolution and tandem mass spectrometry. This emerging experimental approach introduces photo-analogs of amino acids within a protein sequence during its recombinant expression, preserves native protein structure and is suitable for mapping the contact between two proteins. The contact surface regions involved in the well-characterized interaction between two molecules of human 14-3-3ζ regulatory protein were used as a model. The employed photo-initiated cross-linking techniques extend the number of residues shown to be within interaction distance in the contact surface of the 14-3-3ζ dimer (Gln8–Met78). The results of this study are in agreement with our previously published data from molecular dynamic calculations based on high-resolution chemical cross-linking data and Hydrogen/Deuterium exchange mass spectrometry. The observed contact is also in accord with the 14-3-3ζ X-ray crystal structure (PDB 3dhr). The results of the present work are relevant to the structural biology of transient interaction in the 14-3-3ζ protein, and demonstrate the ability of the chosen methodology (the combination of photo-initiated cross-linking protein nanoprobes and mass spectrometry analysis) to map the protein-protein interface or regions with a flexible structure.


20 November 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMateusz Stoszko
Mateusz Stoszko
AAAbdullah M.S. Al-Hatmi
Abdullah M.S. Al-Hatmi
AŠAnton Škríba
Anton Škríba
MRMichael Roling
Michael Roling
ENEnrico Ne
Enrico Ne
TMTokameh Mahmoudi
Tokameh Mahmoudi
A leading pharmacological strategy towards HIV cure requires “shock” or activation of HIV gene expression in latently infected cells with Latency Reversal Agents (LRAs) followed by their subsequent clearance. In a screen for novel LRAs we used fungal secondary metabolites (extrolites) as a source of bio-active molecules. Using orthogonal mass spectrometry (MS) coupled to latency reversal bioassays, we identified gliotoxin (GTX) as a novel LRA. GTX significantly induced HIV-1 gene expression in latent ex vivo infected primary cells and in CD4+ T cells from all aviremic HIV-1+ participants. RNA sequencing identified 7SK RNA, the scaffold of the P-TEFb inhibitory 7SK snRNP complex to be significantly reduced upon GTX treatment of independent donor CD4+T cells. GTX disrupted 7SK snRNP, releasing active P-TEFb, which then phosphorylated RNA Pol II CTD, inducing HIV transcription. Our data highlight the power of combining a medium throughput bioassay, mycology and orthogonal mass spectrometry to identify novel potentially therapeutic compounds.